1
|
Moradkhani K, Cuisset L, Boisseau P, Pichon O, Lebrun M, Hamdi-Rozé H, Maurin ML, Gruchy N, Manca-Pellissier MC, Malzac P, Bilan F, Audrezet MP, Saugier-Veber P, Fauret-Amsellem AL, Missirian C, Kuentz P, Egea G, Guichet A, Creveaux I, Janel C, Harzallah I, Touraine R, Goumy C, Joyé N, Puechberty J, Haquet E, Chantot-Bastaraud S, Schmitt S, Gosset P, Duban-Bedu B, Delobel B, Vago P, Vialard F, Gomes DM, Siffroi JP, Bonnefont JP, Dupont JM, Jonveaux P, Doco-Fenzy M, Sanlaville D, Le Caignec C. Risk estimation of uniparental disomy of chromosome 14 or 15 in a fetus with a parent carrying a non-homologous Robertsonian translocation. Should we still perform prenatal diagnosis? Prenat Diagn 2019; 39:986-992. [PMID: 31273809 DOI: 10.1002/pd.5518] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 06/07/2019] [Accepted: 06/28/2019] [Indexed: 11/09/2022]
Abstract
OBJECTIVE Uniparental disomy (UPD) testing is currently recommended during pregnancy in fetuses carrying a balanced Robertsonian translocation (ROB) involving chromosome 14 or 15, both chromosomes containing imprinted genes. The overall risk that such a fetus presents a UPD has been previously estimated to be around ~0.6-0.8%. However, because UPD are rare events and this estimate has been calculated from a number of studies of limited size, we have reevaluated the risk of UPD in fetuses for whom one of the parents was known to carry a nonhomologous ROB (NHROB). METHOD We focused our multicentric study on NHROB involving chromosome 14 and/or 15. A total of 1747 UPD testing were performed in fetuses during pregnancy for the presence of UPD(14) and/or UPD(15). RESULT All fetuses were negative except one with a UPD(14) associated with a maternally inherited rob(13;14). CONCLUSION Considering these data, the risk of UPD following prenatal diagnosis of an inherited ROB involving chromosome 14 and/or 15 could be estimated to be around 0.06%, far less than the previous estimation. Importantly, the risk of miscarriage following an invasive prenatal sampling is higher than the risk of UPD. Therefore, we do not recommend prenatal testing for UPD for these pregnancies and parents should be reassured.
Collapse
Affiliation(s)
| | - Laurence Cuisset
- Laboratory of Genetics and Molecular Biology, Institute Cochin and Cochin Hospital, APHP, Paris Descartes University, Paris, France
| | | | - Olivier Pichon
- Service de Génétique Médicale, CHU Nantes, Nantes, France
| | - Marine Lebrun
- Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France
| | - Houda Hamdi-Rozé
- Department of Molecular Genetics and Genomics, CHU Rennes, Rennes, France
| | - Marie-Laure Maurin
- Service d'Histologie, Embryologie, Cytogénétique., Groupe Hospitalier Necker-Enfants Malades, Paris, France
| | - Nicolas Gruchy
- Service de Génétique, CHU Caen, Université Caen Normandie, Caen, France
| | | | - Perrine Malzac
- Département de Génétique Médicale, Assistance Publique- Hôpitaux de Marseille, Marseille, France
| | | | | | - Pascale Saugier-Veber
- Department of Genetics, Normandy Centre for Genomic Medicine and Personalized Medicine, Rouen University Hospital, Rouen, France
| | - Anne-Laure Fauret-Amsellem
- Department of Genetics, Robert-Debré Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Chantal Missirian
- Département de Génétique Médicale, Assistance Publique- Hôpitaux de Marseille, Marseille, France
| | - Paul Kuentz
- Génétique Biologique Histologie, Centre Hospitalier Universitaire de Besançon, Besançon, France
| | - Gregory Egea
- Laboratoire de Biologie Médicale GEN-BIO, Clermont-Ferrand, France
| | | | - Isabelle Creveaux
- Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Caroline Janel
- Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Ines Harzallah
- Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France
| | - Renaud Touraine
- Service de Génétique-Laboratoire de Biologie Moléculaire, CHU-Hôpital Nord, Saint-Etienne, France
| | - Carole Goumy
- Cytogénétique Médicale, CHU Estaing, Clermont-Ferrand, France.,U1240 Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France
| | - Nicole Joyé
- Physiopathologie des Maladies Génétiques d'Expression Pédiatrique, Sorbonne Université, INSERM, Paris, France
| | - Jacques Puechberty
- Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France
| | - Emmanuelle Haquet
- Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France
| | | | | | - Philippe Gosset
- Diagnostic Préimplantatoire, Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Bénédicte Duban-Bedu
- Centre de Génétique Chromosomique, GH de l'Institut Catholique de Lille-Hopital Saint Vincent de Paul, Lille, France
| | - Bruno Delobel
- Centre de Génétique Chromosomique, GH de l'Institut Catholique de Lille-Hopital Saint Vincent de Paul, Lille, France
| | - Philippe Vago
- Cytogénétique Médicale, CHU Estaing, Clermont-Ferrand, France.,U1240 Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, INSERM, Clermont-Ferrand, France
| | - François Vialard
- Unité de Cytogénétique, CHI de Poissy St Germain en Laye, Poissy, France.,EA7404-GIG, UFR des Sciences de la Santé Simone Veil, UVSQ, Montigny-le-Bretonneux, France
| | - Denise Molina Gomes
- Unité de Cytogénétique, CHI de Poissy St Germain en Laye, Poissy, France.,EA7404-GIG, UFR des Sciences de la Santé Simone Veil, UVSQ, Montigny-le-Bretonneux, France
| | - Jean-Pierre Siffroi
- Physiopathologie des Maladies Génétiques d'Expression Pédiatrique, Sorbonne Université, INSERM, Paris, France
| | - Jean-Paul Bonnefont
- Service d'Histologie, Embryologie, Cytogénétique., Groupe Hospitalier Necker-Enfants Malades, Paris, France
| | - Jean-Michel Dupont
- Laboratoire de Cytogénétique, HUPC Hôpital Cochin, APHP; Université Paris Descartes, Paris, France
| | - Philippe Jonveaux
- Laboratoire de Génétique, CHRU Nancy, Inserm U1256, Université de Lorraine, Nancy, France
| | - Martine Doco-Fenzy
- Service de Génétique, CHU REIMS, EA3801, UFR de Médecine REIMS, Reims, France
| | - Damien Sanlaville
- Department of Genetics, Lyon University Hospitals, Lyon, France.,Claude Bernard Lyon I University; Lyon Neuroscience Research Centre, CNRS UMR5292, INSERM, Lyon, France
| | | |
Collapse
|
2
|
Alby C, Boutaud L, Bonnière M, Collardeau-Frachon S, Guibaud L, Lopez E, Bruel AL, Aral B, Sonigo P, Roth P, Vibert-Guigue C, Castaigne V, Carbonne B, Joyé N, Faivre L, Cordier MP, Bernabe Gelot A, Clementi M, Mammi I, Vekemans M, Razavi F, Gonzales M, Thauvin-Robinet C, Attié-Bitach T. In utero ultrasound diagnosis of corpus callosum agenesis leading to the identification of orofaciodigital type 1 syndrome in female fetuses. Birth Defects Res 2017; 110:382-389. [PMID: 29193896 DOI: 10.1002/bdr2.1154] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Revised: 10/09/2017] [Accepted: 10/13/2017] [Indexed: 01/25/2023]
Abstract
BACKGROUND OFD1 syndrome is a rare ciliopathy inherited on a dominant X-linked mode, typically lethal in males in the first or second trimester of pregnancy. It is characterized by oral cavity and digital anomalies possibly associated with cerebral and renal signs. Its prevalence is between 1/250,000 and 1/50,000 births. It is due to heterozygous mutations of OFD1 and mutations are often de novo (75%). Familial forms show highly variable phenotypic expression. OFD1 encodes a protein involved in centriole growth, distal appendix formation, and ciliogenesis. CASES We report the investigation of three female fetuses in which corpus callosum agenesis was detected by ultrasound during the second trimester of pregnancy. In all three fetuses, fetopathological examination allowed the diagnosis of OFD1 syndrome, which was confirmed by molecular analysis. CONCLUSIONS To our knowledge, these are the first case reports of antenatal diagnosis of OFD1 syndrome in the absence of familial history, revealed following detection of agenesis of the corpus callosum. They highlight the impact of fetal examination following termination of pregnancy for brain malformations. They also highlight the contribution of ciliary genes to corpus callosum development.
Collapse
Affiliation(s)
- Caroline Alby
- INSERM U1163, Institut Imagine, Université Paris Descartes, Paris, France.,Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Lucile Boutaud
- INSERM U1163, Institut Imagine, Université Paris Descartes, Paris, France.,Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Maryse Bonnière
- Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Sophie Collardeau-Frachon
- Département d'anatomopathologie, Hôpital-Femme-Mère-Enfant, Hospices Civils de Lyon, Lyon, France.,Université Claude Bernard Lyon I, CHU de Lyon, Lyon, France
| | - Laurent Guibaud
- Université Claude Bernard Lyon I, CHU de Lyon, Lyon, France.,Service de radiologie, Hôpital-Femme-Mère-Enfant, Hospices Civils de Lyon, Lyon, France
| | - Estelle Lopez
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Grand-Est, Hôpital d'Enfants, FHU TRANSLAD CHU Dijon Bourgogne, Dijon, France.,UMR 1231, GAD Inserm Université de Bourgogne, Dijon, France
| | - Ange-Line Bruel
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Grand-Est, Hôpital d'Enfants, FHU TRANSLAD CHU Dijon Bourgogne, Dijon, France.,UMR 1231, GAD Inserm Université de Bourgogne, Dijon, France
| | - Bernard Aral
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Grand-Est, Hôpital d'Enfants, FHU TRANSLAD CHU Dijon Bourgogne, Dijon, France.,UMR 1231, GAD Inserm Université de Bourgogne, Dijon, France
| | - Pascale Sonigo
- Service de Radiologie Pédiatrique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Philippe Roth
- Service de Gynécologie Obstétrique, Necker-Enfants Malades, APHP, Paris, France
| | - Claude Vibert-Guigue
- Service de Gynécologie-Obstétrique, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France
| | - Vanina Castaigne
- Unité de Diagnostic Anténatal, Service de Gynécologie Obstétrique, Hôpital Intercommunal de Créteil, Créteil Cedex, France
| | - Bruno Carbonne
- Service Département de Gynécologie-Obstétrique, Hôpital Princesse Grace, Monaco
| | - Nicole Joyé
- Département de Génétique Médicale, Hôpital Armand Trousseau, APHP, UPMC-Sorbonne Universités, Paris, France
| | - Laurence Faivre
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Grand-Est, Hôpital d'Enfants, FHU TRANSLAD CHU Dijon Bourgogne, Dijon, France.,UMR 1231, GAD Inserm Université de Bourgogne, Dijon, France
| | | | | | - Maurizio Clementi
- Sezione di Genetica Clinica Epidemiologica, Dipartimento di Pediatria, Azienda Ospedaliera Universitaria di Padova, Padova, Italia
| | - Isabella Mammi
- Ambulatorio di Genetica Medica, Ospedale Dolo, Dolo, Italia
| | - Michel Vekemans
- INSERM U1163, Institut Imagine, Université Paris Descartes, Paris, France.,Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Féréchté Razavi
- INSERM U1163, Institut Imagine, Université Paris Descartes, Paris, France.,Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - Marie Gonzales
- Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France.,Département de Génétique Médicale, Hôpital Armand Trousseau, APHP, UPMC-Sorbonne Universités, Paris, France
| | - Christel Thauvin-Robinet
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Grand-Est, Hôpital d'Enfants, FHU TRANSLAD CHU Dijon Bourgogne, Dijon, France.,UMR 1231, GAD Inserm Université de Bourgogne, Dijon, France
| | - Tania Attié-Bitach
- INSERM U1163, Institut Imagine, Université Paris Descartes, Paris, France.,Unité d'Embryofoetopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, APHP, Paris, France
| |
Collapse
|
3
|
Kuentz P, Fraitag S, Gonzales M, Dhombres F, St‐Onge J, Duffourd Y, Joyé N, Jouannic J, Picard A, Marle N, Thevenon J, Thauvin‐Robinet C, Faivre L, Rivière J, Vabres P. Mosaic‐activating
FGFR2
mutation in two fetuses with papillomatous pedunculated sebaceous naevus. Br J Dermatol 2016; 176:204-208. [DOI: 10.1111/bjd.14681] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/12/2016] [Indexed: 01/14/2023]
Affiliation(s)
- P. Kuentz
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Laboratoire de Génétique Chromosomique et Moléculaire Plateau Technique de Biologie Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Génétique Biologique Histologie Centre Hospitalier Universitaire de Besançon F‐25000 Besançon France
| | - S. Fraitag
- Service d'Anatomie et de Cytologie Pathologiques APHP Groupe Hospitalier Necker‐Enfants Malades F‐75743 Paris France
| | - M. Gonzales
- Service de Médecine Fœtale Centre Pluridisciplinaire de Diagnostic Prénatal de l'Est Parisien APHP Hôpital Armand Trousseau Université Pierre et Marie Curie Paris France
| | - F. Dhombres
- Service de Médecine Fœtale Centre Pluridisciplinaire de Diagnostic Prénatal de l'Est Parisien APHP Hôpital Armand Trousseau Université Pierre et Marie Curie Paris France
| | - J. St‐Onge
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - Y. Duffourd
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - N. Joyé
- Département de Génétique Médicale APHP Hôpital Armand Trousseau Université Pierre et Marie Curie Paris France
| | - J.‐M. Jouannic
- Service de Médecine Fœtale Centre Pluridisciplinaire de Diagnostic Prénatal de l'Est Parisien APHP Hôpital Armand Trousseau Université Pierre et Marie Curie Paris France
| | - A. Picard
- Service de Chirurgie Maxillo‐Faciale et Chirurgie Plastique APHP Groupe Hospitalier Necker‐Enfants Malades F‐75743 Paris France
- Centre de Référence Malformations Rares de la Face et de la Cavité Buccale UFR Paris Descartes Université Paris France
| | - N. Marle
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Laboratoire de Génétique Chromosomique et Moléculaire Plateau Technique de Biologie Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - J. Thevenon
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Service de Pédiatrie 1 et de Génétique Médicale Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - C. Thauvin‐Robinet
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Service de Pédiatrie 1 et de Génétique Médicale Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - L. Faivre
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Service de Pédiatrie 1 et de Génétique Médicale Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - J.‐B. Rivière
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Laboratoire de Génétique Chromosomique et Moléculaire Plateau Technique de Biologie Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| | - P. Vabres
- Equipe d'Accueil 4271 Génétique des Anomalies du Développement Université de Bourgogne Franche‐Comté F‐21079 Dijon France
- Fédération Hospitalo‐Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD) Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
- Service de Dermatologie Centre Hospitalo‐Universitaire Dijon‐Bourgogne F‐21079 Dijon France
| |
Collapse
|
4
|
Lefebvre M, Dufernez F, Bruel AL, Gonzales M, Aral B, Saint-Onge J, Gigot N, Desir J, Daelemans C, Jossic F, Schmitt S, Mangione R, Pelluard F, Vincent-Delorme C, Labaune JM, Bigi N, D'Olne D, Delezoide AL, Toutain A, Blesson S, Cormier-Daire V, Thevenon J, El Chehadeh S, Masurel-Paulet A, Joyé N, Vibert-Guigue C, Rigonnot L, Rousseau T, Vabres P, Hervé P, Lamazière A, Rivière JB, Faivre L, Laurent N, Thauvin-Robinet C. Severe X-linked chondrodysplasia punctata in nine new female fetuses. Prenat Diagn 2015; 35:675-84. [PMID: 25754886 DOI: 10.1002/pd.4591] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2014] [Revised: 02/09/2015] [Accepted: 02/28/2015] [Indexed: 11/06/2022]
Abstract
OBJECTIVES Conradi-Hünermann-Happle [X-linked dominant chondrodysplasia punctata 2 (CDPX2)] syndrome is a rare X-linked dominant skeletal dysplasia usually lethal in men while affected women show wide clinical heterogeneity. Different EBP mutations have been reported. Severe female cases have rarely been reported, with only six antenatal presentations. METHODS To better characterize the phenotype in female fetuses, we included nine antenatally diagnosed cases of women with EBP mutations. All cases were de novo except for two fetuses with an affected mother and one case of germinal mosaicism. RESULTS The mean age at diagnosis was 22 weeks of gestation. The ultrasound features mainly included bone abnormalities: shortening (8/9 cases) and bowing of the long bones (5/9), punctuate epiphysis (7/9) and an irregular aspect of the spine (5/9). Postnatal X-rays and examination showed ichthyosis (8/9) and epiphyseal stippling (9/9), with frequent asymmetric short and bowed long bones. The X-inactivation pattern of the familial case revealed skewed X-inactivation in the mildly symptomatic mother and random X-inactivation in the severe fetal case. Differently affected skin samples of the same fetus revealed different patterns of X-inactivation. CONCLUSION Prenatal detection of asymmetric shortening and bowing of the long bones and cartilage stippling should raise the possibility of CPDX2 in female fetuses, especially because the majority of such cases involve de novo mutations.
Collapse
Affiliation(s)
- Mathilde Lefebvre
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, France.,GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France.,Service d'Anatomo-Pathologie, Faculté de Médecine de Dijon, Dijon, France
| | - Fabienne Dufernez
- APHP, Hôpital Saint-Antoine, Biochimie B, Laboratoire de Référence pour le Diagnostic Génétique des Maladies Rares, Paris, France
| | - Ange-Line Bruel
- GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - Marie Gonzales
- Service de Génétique et d'Embryologie Médicales, Université Paris VI, Hôpital Trousseau, Paris, France
| | - Bernard Aral
- Laboratoire de Génétique Moléculaire, CHU Dijon, France
| | | | - Nadège Gigot
- Laboratoire de Génétique Moléculaire, CHU Dijon, France
| | - Julie Desir
- Center for Medical Genetics, Hospital Erasme, ULB, Brussels, Belgium
| | - Caroline Daelemans
- Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire, Hôpital Erasme, Université Libre de Bruxelles, Brussel, Belgium
| | | | | | | | - Fanny Pelluard
- Service de pathologie, CHU de Bordeaux, Bordeaux, France
| | | | | | - Nicole Bigi
- Génétique médicale, CHRU Arnaud de Villeneuve, Montpellier, France
| | | | | | - Annick Toutain
- Service de Génétique, Centre Hospitalo-Universitaire Tours, Tours, France
| | - Sophie Blesson
- Service de Génétique, Centre Hospitalo-Universitaire Tours, Tours, France
| | | | - Julien Thevenon
- GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - Salima El Chehadeh
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, France.,GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - Alice Masurel-Paulet
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, France
| | - Nicole Joyé
- Service de Génétique et d'Embryologie Médicales, Université Paris VI, Hôpital Trousseau, Paris, France
| | - Claude Vibert-Guigue
- Service de Gynécologie-Obstétrique, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Luc Rigonnot
- Service de Gynécologie-Obstétrique, Centre Hospitalier Sud Francilien (CHSF), Corbeil-Essonnes, France
| | | | - Pierre Vabres
- GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France.,Service de dermatologie, Hôpital Le Bocage, Dijon, France
| | - Philippe Hervé
- Service de Gynécologie, Centre Hospitalo-Universitaire Tours, Tours, France
| | - Antonin Lamazière
- Laboratory of Mass Spectrometry-APLIPID, Faculté de Médecine Pierre et Marie Curie, ER7-UPMC, Paris, France
| | - Jean-Baptiste Rivière
- GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France.,Laboratoire de Génétique Moléculaire, CHU Dijon, France
| | - Laurence Faivre
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, France.,GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - Nicole Laurent
- Service d'Anatomo-Pathologie, Faculté de Médecine de Dijon, Dijon, France
| | - Christel Thauvin-Robinet
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, France.,GAD: EA4271 « Génétique des Anomalies du Développement » (GAD), FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| |
Collapse
|
5
|
Rouen A, Balet R, Dorna M, Hyon C, Pollet-Villard X, Chantot-Bastaraud S, Joyé N, Portnoï MF, Cassuto NG, Siffroi JP. Discontinuous gradient centrifugation (DGC) decreases the proportion of chromosomally unbalanced spermatozoa in chromosomal rearrangement carriers. Hum Reprod 2013; 28:2003-9. [PMID: 23633550 DOI: 10.1093/humrep/det121] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
STUDY QUESTION Can the proportion of unbalanced spermatozoa in chromosomal rearrangement carriers be decreased through the use of discontinuous gradient centrifugation (DGC)? SUMMARY ANSWER DGC significantly decreases the proportion of genetically unbalanced spermatozoa in chromosomal rearrangement carriers. WHAT IS KNOWN ALREADY Chromosomal rearrangement carriers present with a certain proportion of unbalanced gametes, which can lead to miscarriages or malformations in the offspring. There is presently no known way to select the balanced spermatozoa and use them for IVF. STUDY DESIGN, SIZE, DURATION The proportion of unbalanced spermatozoa after DGC was compared with that before DGC in 21 patients with a chromosomal rearrangement. At least 500 spermatozoa were analysed per observation. PARTICIPANTS/MATERIALS, SETTING, METHODS Twenty-one male patients with a chromosomal rearrangement were included in this prospective study. They initially consulted for infertility, recurrent miscarriages or a history of abnormal pregnancy. The samples were split into two, with one part undergoing DGC and the other being immediately fixed. Fluorescence in situ hybridization was performed to establish the chromosome segregation pattern of each spermatozoon. MAIN RESULTS AND THE ROLE OF CHANCE DGC significantly decreased the proportion of unbalanced spermatozoa in all but 1 of the 21 chromosomal rearrangement carriers (P < 0.05). LIMITATIONS, REASONS FOR CAUTION Although DGC reduces the proportion of unbalanced spermatozoa in ejaculates from patients with chromosome rearrangements this elimination is only partial and some abnormal spermatozoa remain. Means to exclude these spermatozoa to ensure that only balanced ones are used in IVF remain to be discovered. The motility and morphology of the sperm before and after DGC were not measured. WIDER IMPLICATIONS OF THE FINDINGS Used in IVF or intrauterine insemination, DGC could decrease the chance that a man carrying a chromosomal rearrangement will father an abnormal fetus.
Collapse
Affiliation(s)
- Alexandre Rouen
- Medical Genetics and Embryology Department, AP-HP, Armand-Trousseau Hospital, 28 avenue du Dr Arnold Netter, Paris, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Quélin C, Loget P, Verloes A, Bazin A, Bessières B, Laquerrière A, Patrier S, Grigorescu R, Encha-Razavi F, Delahaye S, Jouannic JM, Carbonne B, D’Hervé D, Aubry MC, Macé G, Harvey T, Ville Y, Viot G, Joyé N, Odent S, Attié-Bitach T, Wolf C, Chevy F, Benlian P, Gonzales M. Phenotypic spectrum of fetal Smith–Lemli–Opitz syndrome. Eur J Med Genet 2012; 55:81-90. [DOI: 10.1016/j.ejmg.2011.12.002] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2011] [Accepted: 12/13/2011] [Indexed: 11/25/2022]
|
7
|
Gonzales M, Verloes A, Saint Frison MH, Perrotez C, Bourdet O, Encha-Razavi F, Joyé N, Taillemite JL, Walbaum R, Pfeiffer R, Maroteaux P. Diaphanospondylodysostosis (DSD): Confirmation of a recessive disorder with abnormal vertebral ossification and nephroblastomatosis. Am J Med Genet A 2005; 136A:373-6. [PMID: 15988748 DOI: 10.1002/ajmg.a.30537] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We report on four patients from three families, with similar radiological findings: absent (or severely delayed) ossification of vertebral bodies and associated anomalies. The babies were stillborn or died soon after birth of respiratory insufficiency. Two patients are sibs (female and male) born to first cousin Malian parents. The two others were non-consanguineous. This perinatally lethal entity comprises short neck, short wide thorax, and normally shaped limbs. Associated, inconstant anomalies are myelomeningocele, cystic kidneys with nephrogenic rests (in the sibs), and cleft palate. Radiologically, the hallmarks are absence of ossification of the vertebral bodies and sacrum, abnormal position of the vertebral pedicles, which are lamellar and angulated, ribbon-like ribs reduced in number, narrow pelvis, upward widening of the iliac wings, and unusual tilt of the ischiopubic rami, contrasting with the normal appendicular skeleton. Maroteaux briefly described one of the patients in the 2002 edition of "Maladies osseuses de l'enfant" and three sibs with similar renal and radiological findings were reported in 2003 in this Journal. Combined with the latter cases, these four new patients allow delineation of a specific lethal AR syndrome with ossification defect of the axial skeleton and renal dysplasia. We propose to name this entity diaphanospondylodysostosis.
Collapse
Affiliation(s)
- Marie Gonzales
- Department of Pathologic Embryology and Cytogenetics, Hôpital Saint Antoine, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Vialard F, Ottolenghi C, Gonzales M, Choiset A, Girard S, Siffroi JP, McElreavey K, Vibert-Guigue C, Sebaoun M, Joyé N, Portnoï MF, Jaubert F, Fellous M. Deletion of 9p associated with gonadal dysfunction in 46,XY but not in 46,XX human fetuses. J Med Genet 2002; 39:514-8. [PMID: 12114486 PMCID: PMC1735174 DOI: 10.1136/jmg.39.7.514] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
MESH Headings
- Abnormalities, Multiple/diagnosis
- Abnormalities, Multiple/genetics
- Abortion, Therapeutic/methods
- Chromosome Deletion
- Chromosomes, Human, Pair 9/genetics
- Disorders of Sex Development
- Female
- Fetus/chemistry
- Fetus/physiology
- Genitalia/abnormalities
- Gestational Age
- Gonadal Dysgenesis, 46,XX/diagnosis
- Gonadal Dysgenesis, 46,XX/genetics
- Gonadal Dysgenesis, 46,XY/diagnosis
- Gonadal Dysgenesis, 46,XY/genetics
- Humans
- In Situ Hybridization, Fluorescence
- Karyotyping
- Male
- Pregnancy
- Pregnancy Trimester, Second
- Prenatal Diagnosis
- Telomere/genetics
- Testis/chemistry
- Testis/physiology
Collapse
Affiliation(s)
- F Vialard
- Service de Cytogénétique et de Foetopathologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Luquet I, Mugneret F, Athis PD, Nadal N, Favre B, Abel C, Chelloug N, Lespinasse J, Portnoi MF, Joyé N, Dupont JM, Lebbar A, Bresson JL, Fellmann F, Siffroi JP, Chantot-Bastaraud S, Chiesa J, Amblard F, Devillard F, Jeandidier E, Boceno M, Rival JM, Bellec V, Lallaoui H, Delobel B, Croquette MF, Benzacken B. French multi-centric study of 2000 amniotic fluid interphase FISH analyses from high-risk pregnancies and review of the literature. Ann Genet 2002; 45:77-88. [PMID: 12119216 DOI: 10.1016/s0003-3995(02)01118-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This prospective and multi-centric study confirms the accuracy and the limitations of interphase FISH and shows that any cytogenetics laboratory can perform this technique. With regard to the technical approach, we think that slides must be examined by two investigators, because the scoring may be subjective. The main problem with the AneuVysion kit concerns the alpha satellite probes, and especially the chromosome 18 probe, which is sometimes very difficult to interpret because of the high variability of the size of the spots, and this may lead to false negative and uninformative cases. The best solution would be to replace these probes by locus-specific probes. Concerning clinical management, we offer interphase FISH only in very high-risk pregnancies or/and at late gestational age because of the cost of the test. We think that an aberrant FISH result can be used for a clinical decision when it is associated with a corresponding abnormal ultrasound scan. In other cases, most of the time, we prefer to wait for the standard karyotype.
Collapse
Affiliation(s)
- I Luquet
- Laboratoire de cytogénétique, CHU le Bocage, 21034 cedex, Dijon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Affiliation(s)
- J Coste
- INSERM Unité 292, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
| | | | | | | | | | | | | |
Collapse
|
11
|
Portnoï MF, Joyé N, Gonzales M, Demczuk S, Fermont L, Gaillard G, Bercau G, Morlier G, Taillemite JL. Prenatal diagnosis by FISH of a 22q11 deletion in two families. J Med Genet 1998; 35:165-8. [PMID: 9507401 PMCID: PMC1051226 DOI: 10.1136/jmg.35.2.165] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
We report on prenatal diagnosis by FISH of a sporadic 22q11 deletion associated with DiGeorge syndrome (DGS) in two fetuses after an obstetric ultrasonographic examination detected cardiac anomalies, an interrupted aortic arch in case 1 and tetralogy of Fallot in case 2. The parents decided to terminate the pregnancies. At necropsy, fetal examination showed characteristic facial dysmorphism associated with congenital malformations, confirming full DGS in both fetuses. In addition to the 22q11 deletion, trisomy X was found in the second fetus and a reciprocal balanced translocation t(11;22) (q23;q11) was found in the clinically normal father of case 1. These findings highlight the importance of performing traditional cytogenetic analysis and FISH in pregnancies with a high risk of having a deletion.
Collapse
Affiliation(s)
- M F Portnoï
- Service d'Embryologie Pathologique et de Cytogénétique, Hôpital Saint-Antoine, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Benzacken B, Siffroi JP, Le Bourhis C, Krabchi K, Joyé N, Maschino F, Viguié F, Soulié J, Gonzales M, Migné G, Bucourt M, Encha-Razavi F, Carbillon L, Taillemite JL. Different proximal and distal rearrangements of chromosome 7q associated with holoprosencephaly. J Med Genet 1997; 34:899-903. [PMID: 9391882 PMCID: PMC1051116 DOI: 10.1136/jmg.34.11.899] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Four new cases of holoprosencephaly are described in fetuses exhibiting abnormal karyotypes with different distal and proximal rearrangements of the long arm of chromosome 7. Three of them showed terminal deletions of chromosome 7q, confirming the importance of the 7q36 region in holoprosencephaly. The karyotype of the fourth fetus showed an apparently balanced de novo translocation, t(7;13) (q21.2;q33), without any visible loss of the distal part of chromosome 7q. The involvement of new genes, different from the human Sonic Hedgehog gene (hShh) responsible for holoprosencephaly, or a positional effect are discussed.
Collapse
Affiliation(s)
- B Benzacken
- Laboratoire d'Histologie, Embryologie, Cytogénétique et Biologie de la Reproduction, Hôpital Jean Verdier, Bondy, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|